Key result
Renal sympathetic denervation reduced mean blood pressure from 181/102.5 mmHg to 137.5/81 mmHg at 6 months in patients with resistant hypertension.
Why the study?
Does radiofrequency ablation of renal sympathetic nerves reduce blood pressure in patients with drug resistant hypertension?
Observational (n=8)
Does radiofrequency ablation of renal sympathetic nerves reduce blood pressure in patients with drug resistant hypertension?
Renal sympathetic denervation using conventional ablation catheters substantially reduced blood pressure and medication burden at 6 months in a small series of patients with resistant hypertension.
May support renal denervation in resistant hypertension; hypothesis-generating case report requiring RCT confirmation.
BACKGROUND: The endovascular approach of ablation of renal sympathetic nerves is found to be effective in the treatment of uncontrolled hypertension. We report here our experience with the procedure in eight patients with drug resistant hypertension. METHODS: We included patients in whom the blood pressure remained above 150/90 mmHg despite being on minimum three antihypertensive drugs. Radiofrequency ablation of the sympathetic nerves of both the renal arteries was done using conventional ablation catheters. The patients were followed at 1-month, 3 months and 6 months post procedure and blood pressure recorded. RESULTS: All patients underwent successful renal sympathetic denervation. The mean blood pressure of the patients was 181/102.5 mmHg before the procedure and the average requirement of antihypertensive drugs per day was 4. A significant reduction in both systolic and diastolic blood pressure was observed post procedure which sustained over the follow up period of six months. The mean blood pressure observed at 1-month, 3 and 6 months were 137.5/80 mmHg, 136/81 mmHg and 137.5/81 mmHg, respectively. The average requirement of the number of antihypertensives also was reduced to 2.5 at the end of 6 months. There were no procedural complications. CONCLUSION: Catheter based renal denervation causes substantial and sustained blood pressure reduction without serious adverse events in patients with resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Manakshe et al. (2013) conducted an observational in drug resistant hypertension (n=8). Renal sympathetic denervation was evaluated on blood pressure reduction. Renal sympathetic denervation reduced mean blood pressure from 181/102.5 mmHg to 137.5/81 mmHg at 6 months in patients with resistant hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: